Acquisition brings millions of provider listings into the Veeva Network, along with validation services and territory-alignment software
Veeva (Pleasanton, CA), a leading CRM vendor serving the life sciences industry exclusively, has followed through on the promise it made at its annual customer meeting in May, buying AdvantageMS (Fort Washington, PA) for an undisclosed sum. The company had announced Veeva Network at that meeting, which will include master-data management and compliance services when it goes live later this year. When Veeva announced this service, it said that the Network will be enhanced by pooling (pending client approval) the HCP data of the customers of its CRM solutions. Through the cloud-based, software-as-a-service CRM platform it pioneered for the life sciences industries, much of these data is already on Veeva servers. In effect, Veeva is crowd-sourcing a data offering for pharma sales operations.
Dan Goldsmith, Veeva GM, says that AdvantageMS brings two valuable assets to the table: it is a Data Base Licensee (DBL) of the master-data products of the American Medical Assn., considered by some as the most authoritative source of physician demographic data; and it has a cloud-based IT solution, AlignPlus, that assists in developing territory alignments and trip itineraries for field sales teams. AdvantageMS claims nearly seven million active healthcare-provider (HCP) listings, including just under one million listings from AMA’s database. “The AdvantageMS team shares many of the same values that our company does, and we are going to continue the collaborative efforts of AdvantageMS with AMA in delivering the best possible provider data,” he says.
Master data management—the compilation of HCP names, addresses, business affiliations and government licenses—is a surprisingly complex task to manage for most pharma companies. Besides the need to continually update new HCP information, pharma sales forces have regulatory requirements and restrictions to meet. This year, the entire process is ramping up to a higher level of complexity as pharma companies are obligated to report aggregate spending on HCPs to the federal government. Goldsmith says that Veeva Network will ultimately include expanded HCP data sets, such as channel preferences and social media activity, to better to maintain communication with prescribers. Veeva is also actively turning Network into a global resources, having already begun developing, through another acquisition, a database for prescribers in China.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.